[1]WHO Guidelines Approved by the Guidelines Review Committee.Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection[EB/OL]. (2015-05) [2017-05].http://www.who.int/hiv/pub/hepatitis/hepatitis-B-quidelines/en/.
|
[2]WHO Guidelines Approved by the Guidelines Review Committee.Guidelines for the screening care and treatment of persons with chronic hepatitis C infection:updated version[EB/OL]. (2016-04) [2017-05].http://apps.who.int/iris/bitstream/10665/205035/1/9789241549615_eng.pdf?ua=1, accessed 6 February2017.
|
[3]BENHAMOU Y, BOCHET M, DI MARTINO V, et al.Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients.The Multivirc Group[J].Hepatology, 1999, 30 (4) :1054-1058.
|
[4]THIO CL, GUO N, XIE C, et al.Global elimination of mother-to-child transmission of hepatitis B:revisiting the current strategy[J].Lancet Infect Dis, 2015, 15 (8) :981-985.
|
[5]PATTON H, TRAN TT.Management of hepatitis B during pregnancy[J].Nat Rev Gastroenterol Hepatol, 2014, 11 (7) :402-409.
|